HOULIHAN LOKEY INC (HLI) Stock News
NYSE:HLI - New York Stock Exchange, Inc. - US4415931009 - Common Stock - Currency: USD
HLI Latest News, Press Releases and Analysis
Houlihan Lokey Reports Third Quarter Fiscal 2025 Financial Results
Houlihan Lokey Strengthens Capital Markets Group With Veteran Hire
Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks
Executives at Bausch Health Cos Inc are shaking up the company’s team of advisers as part of the latest in a years-long effort to tackle some of its approximately $20 billion dollars of debt and enable a crucial asset sale.
Houlihan Lokey Grows Consumer Health Coverage Capabilities With Experienced Hire
Houlihan Lokey Announces Release Date for Third Quarter Results for Fiscal Year 2025
Houlihan Lokey: The Rising Star in Investment Banking
Houlihan Lokey to Present at the Goldman Sachs 2024 US Financial Services Conference
Northvolt Hires Houlihan Lokey as It Seeks Funds for Turnaround
Embattled electric-vehicle battery maker Northvolt AB hired financial adviser Houlihan Lokey Inc. to help it raise funds to turn its business around, according to people with knowledge of the matter.
Houlihan Lokey Bolsters Capital Markets Team With Senior Hire
Nutrisystem, Jenny Craig Owner Wellful Prepares a Debt Overhaul
Battling the increasing allure and accessibility of drugs like Ozempic, the company behind last-generation weight-loss and diet plans Jenny Craig and Nutrisystem is experiencing losses so sharp it’s struggling to pay interest on its loans.
Houlihan Lokey Further Expands Its Software Coverage Capabilities With Senior Hire
Houlihan Lokey Acquires PSL
Houlihan Lokey Reports Second Quarter Fiscal 2025 Financial Results
LPL Financial Holdings Stock Flashes Improved Relative Price Strength
On Tuesday, LPL Financial Holdings stock earned an upgrade to its Relative Strength (RS) Rating, from 67 to 71.
Houlihan Lokey Grows Capital Markets Team With Seasoned Hire
PE Firms Said to Circle German Vitamin Supplement Maker Orthomol
CVC Capital Partners and L Catterton are among the private equity firms bidding for German premium vitamin supplement maker Orthomol, people familiar with the matter said.
Charles Schwab Stock Earns RS Rating Upgrade
Charles Schwab stock had its RS Rating upgraded from 67 to 73 Thursday — a nice improvement, but shy of the 80-plus score you prefer to see.
Houlihan Lokey Announces Release Date for Second Quarter Results for Fiscal Year 2025
Spandex Maker Lycra Talks to Creditors as Debt Maturities Near
Textile company Lycra Co. is in talks with its creditors about extending its more than $1 billion in looming debt maturities.
Futu Holdings Stock Scores IBD Rating Upgrade
A Relative Strength Rating upgrade for Futu Holdings ADR shows improving technical performance. Will it continue?
Macquarie Weighs Stake Sale in $1.6 Billion Wavenet
Macquarie Group Ltd. is weighing a stake sale in Wavenet, an IT services provider in the UK, which could be valued at £1.2 billion ($1.6 billion) or more in a deal, people with knowledge of the matter said.